TY - JOUR KW - Abscess KW - Adolescent KW - Anti-Inflammatory Agents, Non-Steroidal KW - Drug Therapy, Combination KW - Glucocorticoids KW - Humans KW - Leprostatic Agents KW - leprosy KW - Male KW - Prednisolone KW - Recurrence KW - Ulnar nerve AU - Agrawal A AU - Dalal M AU - Makkannavar J H AU - Shetty J P AB -
The introduction of multidrug therapy has efficiently controlled leprosy in developing countries. However, Mycobacterium laprae may survive and cause relapse despite adequate treatment with antileprosy drugs. Relapse may be characterized by a combination of new signs or symptoms and presence of acid-fast bacilli on skin or nerve biopsy samples. We report a case of a child in whom ulnar abscess developed 12 months after successful completion of multidrug therapy with clinical and histopathological evidence of relapse.
BT - Pediatric neurosurgery C1 - http://www.ncbi.nlm.nih.gov/pubmed/15995337?dopt=Abstract DA - 2005 May-Jun DO - 10.1159/000085877 IS - 3 J2 - Pediatr Neurosurg LA - eng N2 -The introduction of multidrug therapy has efficiently controlled leprosy in developing countries. However, Mycobacterium laprae may survive and cause relapse despite adequate treatment with antileprosy drugs. Relapse may be characterized by a combination of new signs or symptoms and presence of acid-fast bacilli on skin or nerve biopsy samples. We report a case of a child in whom ulnar abscess developed 12 months after successful completion of multidrug therapy with clinical and histopathological evidence of relapse.
PY - 2005 SP - 162 EP - 4 T2 - Pediatric neurosurgery TI - Ulnar nerve abscess and relapse in a patient with indeterminate leprosy 1 year after completion of multidrug therapy. VL - 41 SN - 1016-2291 ER -